CClinicalTrials.gg
CompletedNCT03911024Updated Oct 17, 2019

Development and Piloting of a Just-in-Time, Personalized HIV Prevention Intervention for Youth Experiencing Homelessness and Unstable Housing

An interventional study of HIV and General health in Behavior, Risk, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Open to participants aged 18 Years to 25 Years. Per ClinicalTrials.gov, last updated 2019-10-17.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

The purpose of this study is develop and pilot test a personalized HIV intervention with youth experiencing homelessness by creating and field testing prevention messages that address real-time predictors (e.g., sexual urge, use to use drugs, and substance use) of HIV risk behaviors,to evaluate the feasibility and acceptability of the intervention and to evaluate the intervention outcome effects on HIV risk behaviors (e.g., condomless sex, number of sexual partners, pre-exposure prophylaxis(PrEP) awareness, substance use during sex,Intravenous(IV)drug use)

02

Conditions studied

  • Behavior, Risk

Keywords

  • HIV prevention
  • homeless
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • English speaking
  • HIV high risk: IV drug user or sexually active youth (sex in the past 3 months) who reports at least one of the following: condomless sex, concurrent sexual partners within 2 weeks,sex with a partner of unknown HIV status, or a bacterial STI in the last 6 months.
  • Homelessness: staying on the streets or in a place not meant for human habitation, a shelter,hotel/motel, or some place they cannot stay for more than 30 days

Exclusion criteria

Exclusion Criteria:

  • Below 6th grade reading level:determined by the Rapid Estimate of Adult Literacy in Medicine Short Form (REALM)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Active comparator
    HIV

    Behavioral: HIV

  • Placebo comparator
    General Health

    Behavioral: General health

Interventions

  • BehavioralHIV

    At the completion of each EMA, participants in the intervention group (n=50) will receive messages that address:1) unsafe sexual behaviors, 2) alcohol/drug use, 3) PrEP interest, and 4) HIV testing. In addition, participants will have access to a button in the app that will link them to resources when/if they are the victim of sexual assault. Finally, intervention arm youth will be asked to set a behavioral goal related to HIV prevention during this session. Those goals will include increasing condom use, PrEP use, non-occupational post-exposure prophylaxis (nPEP) use, reducing number of sexual partners, not having sex with using drugs or drinking alcohol, avoiding IV drug use, getting testing for HIV, and testing and treating sexually transmitted infections (STIs) as needed

  • BehavioralGeneral health

    Participants in the attention control condition (n=50) will answer the same EMA items as the Intervention group. However, the intervention messages will contain content related to nutrition, physical activity, sleep hygiene, and tobacco use. Finally, control arm youth will be asked to set a behavioral goal related to general health during this session.Those goals will include getting 7+ hours of sleep, eating \>= 5 servings of fruits or vegetables, not using tobacco products, exercising at least 60 minutes.

06

What researchers measure

Primary outcomes

  1. Feasibility as assessed by number recruited

    Number recruited is number of eligible youth minus number who refuse to participate.

    Time frame: baseline

  2. Feasibility as assessed by number of participants who complete the study

    Time frame: 6 weeks

  3. Feasibility as assessed by number of staff hours required

    Time frame: 6 weeks

  4. Feasibility as assessed by number of participants who damage or lose phones

    Time frame: 6 weeks

  5. Acceptability as assessed by score on the System Usability Scale (SUS)

    The System Usability Scale (SUS) consists of 10 items on a 5-point (0-4) Likert scale and is designed to assess acceptability of a product. Overall score ranges from 0 to 100, with higher scores indicating greater acceptability.

    Time frame: 6 weeks

  6. Acceptability as assessed by score on the Mobile App Rating Scale (MARS)

    The Mobile App Rating Scale (MARS) consists of 23 items on a 5-point (1-5) scale is designed to score apps on the criteria of engagement, functionality, aesthetics, and information quality (sub-scales). Total score is determined by calculating the mean of each sub-scale and an overall mean score. High mean scores indicate a higher quality app.

    Time frame: 6 weeks

  7. Number of participants who complete greater than 80% of the Ecological Momentary Assessments (EMAs)

    Time frame: 6 weeks

  8. Number of participants who read greater than 80% of Just-In-Time Adaptive Intervention (JITAI) messages

    Time frame: 6 weeks

  9. Effect on HIV risk behaviors as assessed by number of participants who use condoms

    Time frame: 6 weeks

  10. Effect on HIV risk as assessed by number who use substances before sex

    Time frame: 6 weeks

  11. Effect on HIV risk as assessed by number of participants who have pre-exposure prophylaxis (PrEP) interest

    Time frame: 6 weeks

  12. Effect on HIV risk as assessed by number of participants who undergo HIV or sexually transmitted infection (STI) testing

    Time frame: 6 weeks

  13. Effect on HIV risk as assessed by number of sexual partners

    Time frame: 6 weeks

07

Study locations

1 site
  • The University of Texas Health Science Center at Houston
    Houston, Texas 77030, United States
08

References and documents

Publications

  • Santa Maria D, Padhye N, Businelle M, Yang Y, Jones J, Sims A, Lightfoot M. Efficacy of a Just-in-Time Adaptive Intervention to Promote HIV Risk Reduction Behaviors Among Young Adults Experiencing Homelessness: Pilot Randomized Controlled Trial. J Med Internet Res. 2021 Jul 6;23(7):e26704. doi: 10.2196/26704. PubMed 34255679 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 17, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03911024
Lead sponsor
The University of Texas Health Science Center, Houston
Responsible party
Diane Santa Maria (Associate Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Apr 10, 2019
Start date
May 20, 2019
Primary completion
Aug 1, 2019
Completion
Aug 1, 2019
Last update
Oct 17, 2019

Study contacts

Diane Santa Maria, DrPH
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion